Microbot Medical Inc. 8-K

What Happened
Microbot Medical Inc. filed a Current Report on Form 8-K on June 2, 2026, disclosing (Item 7.01) a press release and (Item 8.01) that it has secured its first North Carolina–based customer for the LIBERTY® Endovascular Robotic System. The press release was furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: June 2, 2026 (Form 8-K, Items 7.01 and 8.01).
• Product: LIBERTY® Endovascular Robotic System; first confirmed customer based in North Carolina.
• The company described this as a continuation of geographic penetration beyond the southeast, mid‑Atlantic and northeast U.S.
• Press release is furnished as Exhibit 99.1 to the 8-K.

Why It Matters
This 8-K documents continued commercial adoption of Microbot’s LIBERTY system and expansion into a new state market (North Carolina). For investors tracking the company’s commercialization progress, the filing provides a concrete, date-stamped example of geographic growth and additional healthcare system acceptance of the product. The disclosure also follows Regulation FD procedures by publicly announcing the development via press release.